Fabienne Drane

Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest)

Thierry Poynard, Pascal Lebray, Patrick Ingiliz et al. · BMC Gastroenterology · 2010 · 199 citations · Full text

Medicine, Internal Medicine, Clinical Epidemiology +11

Validation of liver fibrosis biomarker (FibroTest) for assessing liver fibrosis progression: Proof of concept and first application in a large population

Thierry Poynard, M. Munteanu, Olivier Deckmyn et al. · Journal of Hepatology · 2012 · 77 citations

Medicine, Internal Medicine, Pathology +14

Applicability and precautions of use of liver injury biomarker FibroTest. A reappraisal at 7 years of age

Thierry Poynard, M. Munteanu, Olivier Deckmyn et al. · BMC Gastroenterology · 2011 · 69 citations · Full text

Medicine, Pathology, Clinical Epidemiology +16

Prospective head-to-head comparison of non-invasive scores for diagnosis of fibrotic MASH in patients with type 2 diabetes

Laurent Castéra, Philippe Garteiser, Cédric Laouenan et al. · Journal of Hepatology · 2024 · 45 citations

Medicine, Endocrinology, Internal Medicine +7

Performance of serum apolipoprotein-A1 as a sentinel of Covid-19

Thierry Poynard, Olivier Deckmyn, Marika Rudler et al. · PLoS ONE · 2020 · 20 citations · Full text

Medicine, Infectious Diseases, Pathology +17